GLP-1 medications help with weight loss by making it easier to cut calories, but a smoothie with almost a full days worth of calories might be counterproductive
This review examines the link between diabetes and neurodegenerative diseases, explores the effects of antidiabetic agents on neurodegeneration, provides a concise overview of the GLP-1 pathway, and discusses both preclinical and clinical trial outcomes of GLP-1RAs for neurodegenerative diseases, including their effects on cognition in AD and PD
Regular review of weight loss progress, typically every three months, allows assessment of treatment response and consideration of whether continuation is appropriate according to NICE TA875, which recommends discontinuation if less than 5% weight loss is achieved after six months at the maintenance dose
After finding success with Ro, and losing 31 pounds, according to PEOPLE , Williams wants to help normalize the use of the medications and conversations surrounding GLP-1s
GLP-1 off shortage list and fallout from Hims, DTC Telehealth